Investigating how neuropeptides and hormones signal in various diseases
Chemical approaches to interrogate neuropeptide and peptide hormone signaling in disease
This study is looking at how certain tiny molecules in our body, called neuropeptides and peptide hormones, communicate with cells, which could help create new treatments for conditions like diabetes, cancer, and other diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Lincoln NIH-funded |
| Lab location | 1 site (Lincoln, United States) |
| Project ID | NIH-11088275 on NIH RePORTER |
What this research studies
This research focuses on understanding the signaling mechanisms of neuropeptides and peptide hormones, which are crucial in treating diseases like neurodegenerative disorders, diabetes, osteoporosis, and cancer. By developing innovative chemical tools, the research aims to identify how these peptides interact with their receptors in the body. This knowledge will help design new therapeutic compounds that can effectively target these signaling pathways. The research employs advanced techniques such as mass spectrometry and chemical probe synthesis to explore these interactions at a molecular level.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from neurodegenerative diseases, diabetes, osteoporosis, or cancer.
Not a fit: Patients with conditions unrelated to neuropeptide or peptide hormone signaling may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for a variety of serious health conditions.
How similar studies have performed: Previous research has shown promise in targeting peptide signaling pathways, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Lincoln, United States
- University of Nebraska Lincoln — Lincoln, United States (Active)
Researchers
- Principal investigator: Checco, James William — University of Nebraska Lincoln
- Study coordinator: Checco, James William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.